{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69097-431",
      "generic_name": "Darifenacin Hydrobromide",
      "labeler_name": "Cipla USA Inc.",
      "brand_name": "Darifenacin",
      "active_ingredients": [
        {
          "name": "DARIFENACIN HYDROBROMIDE",
          "strength": "7.5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69097-431-02",
          "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-02)",
          "marketing_start_date": "20160901",
          "sample": false
        },
        {
          "package_ndc": "69097-431-05",
          "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-05)",
          "marketing_start_date": "20160901",
          "sample": false
        },
        {
          "package_ndc": "69097-431-15",
          "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-431-15)",
          "marketing_start_date": "20160901",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Cipla USA Inc."
        ],
        "rxcui": [
          "485421",
          "485423"
        ],
        "spl_set_id": [
          "6e8470d1-c3e6-4644-b70a-aa47ddf79676"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "CR02EYQ8GV"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, EXTENDED RELEASE",
      "spl_id": "99ca2704-b757-4f10-be5c-bd01dff69b10",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160901",
      "product_id": "69097-431_99ca2704-b757-4f10-be5c-bd01dff69b10",
      "application_number": "ANDA207664",
      "brand_name_base": "Darifenacin",
      "pharm_class": [
        "Cholinergic Muscarinic Antagonist [EPC]",
        "Cholinergic Muscarinic Antagonists [MoA]"
      ]
    }
  ]
}